Sign up to receive email updates, action alerts, health tips, promotions to support our work and more from EWG. You can opt-out at any time. [Privacy]

 

Rethinking Carcinogens

New view of cancer development focuses on subtle, combined effects

July 16, 2015

Rethinking Carcinogens: Appendix 1

Hallmark-disrupting chemicals investigated by the Halifax Project

12-O-Tetradecanoylphorbol-13-acetate (TPA)
2,2-bis-(p-hydroxyphenyl)-1,1,1-trichloroethane (HPTE)
4-Nonylphenol
Acetaminophen
Acrolein
Acrylamide
Alloy particles (tungsten/nickel/cobalt)
Atrazine
Azamethiphos
Benomyl
Benzo(a)pyrene
Biorhythms/Melatonin
Biphenyl
Bisphenol A
Bisphenol AF
Butyltins (such as TBT)
C.I. solvent yellow 14
Cadmium
Carbendazim
Carbon black
Carbon nanotubes
Chlorothalonil
Chlorpyrifos
Cobalt
Copper
Cotinine
Cypermethrin
Cyprodinil
DDT
Diazinon
Dibutyl phthalate (DBP)
Dichlorvos
Diethylhexyl phthalate (DEHP)
Diethylstilbestrol
Diniconazole
Edible oil adulterants
Etoxazole
Fluoxastrobin
Folpet
Hexacholorobenzene
Hexythiazox
Imazalil
Iron
Lactofen
Lead
Lindane
Linuron
Malathion
Maneb
Mercury
Methoxychlor
Methylene bis(thiocyanate)
Methylmercury
Na-selenite
Nickel
Nickel-derived compounds,
(e.g. Nickel chloride)
Nitric oxide
Oxyfluorfen
Paraquat
Perfluorooctane sulfonate (PFOS)
Phenobarbital
Phosalone
Phthalates
Polybrominated diphenyl ethers (PBDEs)
Pyraclostrobin
Pyridaben
Quinones
Reserpine
Rotenone
Sulfur dioxide
Tetrabromobisphenol A
Tetrabromobisphenol A dimethyl ether
Titanium dioxide nanoparticles
Tributyltin chloride
Triclosan
Tungsten
Vinclozolin
Ziram